The rules governing the way over-the-counter medicines are regulated are set to change as the government strives to reduce the …
England's general practices are being urged to seize their opportunity to re-build the NHS as a primary care-led, patient-centred service, …
Hundreds of thousands of patients with early or late-onset Alzheimer's disease (AD) are to be denied access to four drugs …
Adventis, the multimedia marketing group has bought healthcare advertising agency Roundhouse for 1.6 million pounds as part of its expansion …
Care UK has signed a contract to provide GP services in Barking and Dagenham, making it the first private company …
The number of Primary Care Trusts in England is to be cut in half from 303 to just 152, the …
GlaxoSmithKline shareholders are using an administrative loophole to protect themselves in the face of a threatening letter campaign by animal …
Acomplia, the first-of-a-kind weight-loss drug, is set to gain approval across Europe within the coming weeks, offering a new hope …
Three early breast cancer drugs are a step closer to overtaking the current gold standard treatment, after preliminary recommendation from …
Every business and every market is unique, but there is a huge expanse of common ground when it comes to …
Pharmacists have been asked to keep an eye out for suspected counterfeit medicines as part of a new awareness-raising initiative.Pharmacists' …
A new insomnia treatment developed by Pfizer and Neurocrine Biosciences has suffered a setback after US regulators said a high-dose …
Specialist pharma company Phytopharm says it is confident of finding a partner to develop and market one of its lead …
Exelon has been launched as the first ever treatment for mild to moderately severe dementia associated with idiopathic Parkinson's disease.The …
A UK blindness charity says patients are being denied a new drug because PCTs are exploiting a delay in NICE's …
PR and medical education group Medicom has launched a new consultancy that offers product and corporate branding services.The new division, …
Experts from the UK's pharmaceutical and biotech industries are to assist the inquiry into the Northwick Park drug trial, which …
AstraZeneca is to buy Cambridge Antibody Technology for 702 million pounds in a bid to expand its reach into biotechnology.Cambridge …
GlaxoSmithKline says new analyses of its antidepressant Seroxat show the drug raises the risk of suicidal behaviour in young adults.The …
Prime Minister Tony Blair has spoken out against animal rights activists, saying it was time for the 'silent majority' to …